Notably, high KYNU expression was linked to better outcomes in two melanoma subtypes: uveal melanoma (UVM) and metastatic skin cutaneous melanoma lesions (SKCM.met) (Figure 8b). This evidence concerns the gene KYNU and uveal melanoma.